Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease.
<h4>Objective</h4>HIBM (Hereditary Inclusion Body Myopathy) is a recessive hereditary disease characterized by adult-onset, slowly progressive muscle weakness sparing the quadriceps. It is caused by a single missense mutation of each allele of the UDP-N-acetylglucosamine 2-epimerase/N-ac...
Guardado en:
Autores principales: | Thomas Paccalet, Zoé Coulombe, Jacques P Tremblay |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/baa8b396f3554e9183633ee5484f1c19 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
GM3 Ganglioside Linked to Neurofibrillary Pathology in a Transgenic Rat Model for Tauopathy
por: Dominika Olešová, et al.
Publicado: (2021) -
Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysis
por: Shaoyong Wu, et al.
Publicado: (2021) - GM crops & food
-
A Single Native Ganglioside GM<sub>1</sub>-Binding Site Is Sufficient for Cholera Toxin To Bind to Cells and Complete the Intoxication Pathway
por: Michael G. Jobling, et al.
Publicado: (2012) -
Interaction between Simian Virus 40 Major Capsid Protein VP1 and Cell Surface Ganglioside GM1 Triggers Vacuole Formation
por: Yong Luo, et al.
Publicado: (2016)